Acadia Healthcare (NASDAQ:ACHC) Shares Down 5.8% – Here’s Why

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares fell 5.8% on Tuesday . The company traded as low as $14.41 and last traded at $14.3530. 187,924 shares were traded during mid-day trading, a decline of 95% from the average session volume of 3,577,125 shares. The stock had previously closed at $15.23.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on ACHC shares. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating on the stock in a report on Wednesday, December 3rd. Raymond James Financial set a $17.00 price objective on Acadia Healthcare in a report on Wednesday, December 3rd. TD Cowen reaffirmed a “reduce” rating on shares of Acadia Healthcare in a research report on Friday, January 16th. KeyCorp dropped their price objective on shares of Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Wednesday, December 3rd. Finally, Mizuho dropped their price target on Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating on the stock in a research note on Thursday, December 18th. Six equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, Acadia Healthcare presently has an average rating of “Hold” and an average price target of $18.62.

Acadia Healthcare Trading Down 13.2%

The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44. The firm has a market cap of $1.22 billion, a P/E ratio of 11.32, a PEG ratio of 4.33 and a beta of 0.88. The company’s 50 day moving average is $14.46 and its two-hundred day moving average is $19.52.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, November 5th. The company reported $0.72 EPS for the quarter, topping the consensus estimate of $0.71 by $0.01. The business had revenue of $851.57 million during the quarter, compared to the consensus estimate of $852.43 million. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.Acadia Healthcare’s revenue was up 4.4% on a year-over-year basis. During the same quarter last year, the company earned $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Large investors have recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Acadia Healthcare by 431.7% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 164,550 shares of the company’s stock valued at $2,335,000 after acquiring an additional 133,600 shares during the last quarter. Bayforest Capital Ltd acquired a new position in Acadia Healthcare during the fourth quarter worth approximately $52,000. Aberdeen Group plc raised its stake in Acadia Healthcare by 72.3% in the fourth quarter. Aberdeen Group plc now owns 743,925 shares of the company’s stock valued at $10,556,000 after buying an additional 312,172 shares during the period. Congress Asset Management Co. lifted its position in shares of Acadia Healthcare by 3.0% in the fourth quarter. Congress Asset Management Co. now owns 137,809 shares of the company’s stock valued at $1,956,000 after buying an additional 3,949 shares during the last quarter. Finally, SG Americas Securities LLC increased its holdings in shares of Acadia Healthcare by 717.8% during the 4th quarter. SG Americas Securities LLC now owns 292,425 shares of the company’s stock worth $4,150,000 after acquiring an additional 256,669 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.